Leon Ekchian
Directeur Général chez NeuroSigma, Inc.
Profil
Leon Ekchian is the founder of NeuroSigma, Inc., a company founded in 2008, where he holds the title of Chief Executive Officer.
He is currently the Chief Executive Officer at Monarch Biosciences, Inc. Dr. Ekchian previously served as the President of Arrowhead Pharmaceuticals, Inc. from 2005 to 2006.
He has an educational background that includes undergraduate, graduate, and doctorate degrees from the Massachusetts Institute of Technology, as well as an MBA from the Anderson School of Management.
Postes actifs de Leon Ekchian
| Sociétés | Poste | Début |
|---|---|---|
NeuroSigma, Inc.
 NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Directeur Général | 01/03/2008 |
Monarch Biosciences, Inc.
 Monarch Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Monarch Biosciences, Inc. engages in the provision of thin film nitinol biomaterial platform for use in advanced medical device, biotechnology, and regenerative medicine products. It offers Titan Flow Diverter and Engineered Lymph Node (ELN). The company was founded on April 12, 2011 and is headquartered in Los Angeles, CA. | Directeur Général | - |
Anciens postes connus de Leon Ekchian
| Sociétés | Poste | Fin |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | President | 02/06/2006 |
Formation de Leon Ekchian
| Massachusetts Institute of Technology | Doctorate Degree |
| Anderson School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Health Technology |
Monarch Biosciences, Inc.
Monarch Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Monarch Biosciences, Inc. engages in the provision of thin film nitinol biomaterial platform for use in advanced medical device, biotechnology, and regenerative medicine products. It offers Titan Flow Diverter and Engineered Lymph Node (ELN). The company was founded on April 12, 2011 and is headquartered in Los Angeles, CA. | Electronic Technology |